ERNEXA THERAPEUTICS INC (ERNA) Stock Price, Quote, News and Overview
NASDAQ:ERNA - Nasdaq - US1140822099 - Common Stock - Currency: USD
ERNA Quote, Performance and Key Statistics
NASDAQ:ERNA (4/29/2025, 9:33:52 AM)
0.202
-0.01 (-4.49%)
The current stock price of ERNA is 0.202 USD. In the past month the price increased by 21.27%. In the past year, price decreased by -88.6%.
ERNA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.63 | 338.42B | ||
| AMGN | AMGEN INC | 14.12 | 150.48B | ||
| GILD | GILEAD SCIENCES INC | 13.53 | 130.55B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1693.93 | 126.29B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.92 | 59.49B | ||
| ARGX | ARGENX SE - ADR | 327.98 | 38.05B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 33.18B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.84B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.87B | ||
| NTRA | NATERA INC | N/A | 20.64B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.81B | ||
| BIIB | BIOGEN INC | 7.14 | 17.20B |
Related stock screener links
About ERNA
Company Profile
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 6 full-time employees. The firm is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The firm seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The firm is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.
Company Info
ERNEXA THERAPEUTICS INC
1035 Cambridge Street, Suite 18A
Cambridge MASSACHUSETTS US
Employees: 8
Company Website: https://www.ernexatx.com/
Investor Relations: https://investor.eternatx.com/
Phone: 16177986700
ERNEXA THERAPEUTICS INC / ERNA FAQ
What is the stock price of ERNEXA THERAPEUTICS INC today?
The current stock price of ERNA is 0.202 USD. The price decreased by -4.49% in the last trading session.
What is the ticker symbol for ERNEXA THERAPEUTICS INC stock?
The exchange symbol of ERNEXA THERAPEUTICS INC is ERNA and it is listed on the Nasdaq exchange.
On which exchange is ERNA stock listed?
ERNA stock is listed on the Nasdaq exchange.
What is ERNEXA THERAPEUTICS INC worth?
ERNEXA THERAPEUTICS INC (ERNA) has a market capitalization of 12.56M USD. This makes ERNA a Nano Cap stock.
How many employees does ERNEXA THERAPEUTICS INC have?
ERNEXA THERAPEUTICS INC (ERNA) currently has 8 employees.
What are the support and resistance levels for ERNEXA THERAPEUTICS INC (ERNA) stock?
ERNEXA THERAPEUTICS INC (ERNA) has a support level at 0.18 and a resistance level at 0.22. Check the full technical report for a detailed analysis of ERNA support and resistance levels.
Should I buy ERNEXA THERAPEUTICS INC (ERNA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ERNA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ERNA, evaluating the profitability, health, valuation and growth aspects
- ERNEXA THERAPEUTICS INC (ERNA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ERNEXA THERAPEUTICS INC (ERNA) Sales and EPS estimates to see what analysts future expectations are.
- ERNEXA THERAPEUTICS INC (ERNA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ERNEXA THERAPEUTICS INC (ERNA) Insider and Institutional Ownership to learn about the owners and their transactions.
- ERNEXA THERAPEUTICS INC (ERNA) Stock Chart to make your own analysis
- ERNEXA THERAPEUTICS INC (ERNA) Latest news and press-releases to stay up to date.
Does ERNEXA THERAPEUTICS INC (ERNA) stock pay dividends?
ERNA does not pay a dividend.
When does ERNEXA THERAPEUTICS INC (ERNA) report earnings?
ERNEXA THERAPEUTICS INC (ERNA) will report earnings on 2025-05-12.
What is the Price/Earnings (PE) ratio of ERNEXA THERAPEUTICS INC (ERNA)?
ERNEXA THERAPEUTICS INC (ERNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.32).
What is the Short Interest ratio of ERNEXA THERAPEUTICS INC (ERNA) stock?
The outstanding short interest for ERNEXA THERAPEUTICS INC (ERNA) is 0.88% of its float. Check the ownership tab for more information on the ERNA short interest.
ERNA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ERNA. When comparing the yearly performance of all stocks, ERNA is a bad performer in the overall market: 97.63% of all stocks are doing better.
ERNA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ERNA. ERNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ERNA Financial Highlights
Over the last trailing twelve months ERNA reported a non-GAAP Earnings per Share(EPS) of -7.32. The EPS decreased by -79.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -845.61% | ||
| ROE | -2619.34% | ||
| Debt/Equity | 0 |
ERNA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to ERNA. The Buy consensus is the average rating of analysts ratings from 6 analysts.